Refresh

AstraZeneca Pharma India Ltd.

Price on BSE   09 Mar,15:29 LIVE
8,700.00
-40.10
(-0.46%)

© 2026 Rediff.com
  • Volume :
  • 420.00
  • Prev Close :
  • 8,740.10
  • Day's H/L (Rs.) :
  • 8,700.00 - 8,476.75
  • 52wk H/L (Rs.) :
  • 10,653.05 - 6,501.60
  • Mkt Cap (Rs. Cr) :
  • 21,750.00
Price on NSE   09 Mar,15:40 LIVE
8,667.50
-37.00
(-0.43%)

© 2026 Rediff.com
  • Volume :
  • 5,828.00
  • Prev Close :
  • 8,704.50
  • Day's H/L (Rs.) :
  • 8,700.00 - 8,474.50
  • 52wk H/L (Rs.) :
  • 10,691.00 - 7,201.15
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Rare-Disease, Cancer Drugs Get Cheaper
Rediff.com   03 Feb 2026
Cancer Therapies Break New Ground
Rediff.com   26 Dec 2025
Report Card - AstraZeneca Pharma India Ltd.
PE Ratios
187.92
EPS (Rs.)
46.30
Sales (Rs. Cr)
611.57
Face Value (Rs.)
2
Net Profit Margin(%)
6.74
Last Bonus
1:1
Last Dividend(%)
1600
Return on Average Equity
15.02

News for AstraZeneca Pharma India Ltd.

AstraZeneca Imfinzi Approved in India for Endometrial Cancer
AstraZeneca Pharma India gets approval to market Imfinzi (Durvalumab) for advanced endometrial cancer treatment in India.
Feb 10, 2026 14:05
AstraZeneca Durvalumab Approved for Gastric Cancer
CDSCO approves AstraZeneca's Durvalumab with chemotherapy for gastric/gastroesophageal junction cancer treatment in India.
Feb 04, 2026 14:19
Starmer Secures UK-China Export & Investment Deals
PM Starmer concludes China visit with multi-billion pound export and investment deals, boosting UK-China relations and trade.
Jan 31, 2026 18:27
AstraZeneca Breast Cancer Drug Approved in India
AstraZeneca receives CDSCO approval to import & sell Datopotamab Deruxtecan for HR-positive, HER2-negative metastatic breast cancer in India.
Dec 18, 2025 18:27
AstraZeneca & Sun Pharma Hyperkalaemia Deal
AstraZeneca partners with Sun Pharma to expand access to Sodium Zirconium Cyclosilicate (SZC) for Hyperkalaemia treatment in India.
Nov 17, 2025 18:26

More News for AstraZeneca Pharma India Ltd. »

News for Pharmaceuticals and health care

Pak PM Announces WFH Amid West Asia Conflict
Pakistan PM announces work from home, 4-day work week due to West Asia conflict, rising oil prices, and potential fuel shortages.
Mar 09, 2026 23:11
LPG Shortage Hits Hotels & Restaurants
Hotel & restaurant associations report commercial LPG cylinder shortage. Seek govt intervention to ensure seamless supply.
Mar 09, 2026 22:49
Air India Flights to Middle East Amid Conflict
Air India & AI Express operate 60 flights to/from Middle East cities. Services adjusted due to conflict & airspace restrictions.
Mar 09, 2026 22:20
ideaForge NATO Drone Training in US
ideaForge launches drone flight-test training for NATO personnel in the US. Enhancing tactical capabilities with SWITCH UAV platform.
Mar 09, 2026 21:51
True North Sells Stake in Anthem Biosciences for Rs 1,261 Cr
True North divests 3.6% stake in Anthem Biosciences for Rs 1,261 crore via open market. HDFC MF & SBI MF acquire 1.65% stake.
Mar 09, 2026 21:51

More News »

Top News

Pak PM Announces WFH Amid West Asia Conflict
Pakistan PM announces work from home, 4-day work week due to West Asia conflict, rising oil prices, and potential fuel shortages.
Mar 09, 2026 23:11
LPG Shortage Hits Hotels & Restaurants
Hotel & restaurant associations report commercial LPG cylinder shortage. Seek govt intervention to ensure seamless supply.
Mar 09, 2026 22:49
Pune Budget 2026-27: Rs 13,995 Cr Outlay
Pune Municipal Corporation unveils Rs 13,995 crore budget for 2026-27, focusing on urban mobility, infrastructure, and merged village development.
Mar 09, 2026 22:40
Air India Flights to Middle East Amid Conflict
Air India & AI Express operate 60 flights to/from Middle East cities. Services adjusted due to conflict & airspace restrictions.
Mar 09, 2026 22:20
NCLAT Rejects Reliance Realty Insolvency Plea
NCLAT dismisses Reliance Realty's appeal against Altruist Customer Management, upholding NCLT order due to pre-existing dispute.
Mar 09, 2026 22:17

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com